FDA Approves the first Actemra biosimilar- called tocilizumab-bavi (Tofidence) or BIIB800 (during development). This IV FORMULATION is approved for use in active RA, polyarticular JIA and systemic JIA. https://t.co/SSKz6RcR5r https://t.co/fLSNHazFS6 https://t.co/pvfrjkOeyW… https://t.co/ASihH17Phu
Links:
FDA Approves Biogen’s TOFIDENCE™ (tocilizumab-bavi), a Biosimilar Referencing A…
https://bit.ly/46foqeO
FDA Approves First Tocilizumab Biosimilar for US Arthritis Patients
https://bit.ly/46iUwGJ
t.co / Twitter
https://bit.ly/46qMwDG
Oct-07-2023
